نتایج جستجو برای: s ataxia frda

تعداد نتایج: 727598  

ژورنال: :مجله دانشگاه علوم پزشکی قم 0
مریم ناصرالاسلامی maryam naseroleslami islamic azad university, science & research branchآزاد اسلامی، واحد علوم و تحقیقات تهران کاظم پریور kazem parivar islamic azad university, science & research branchآزاد اسلامی، واحد علوم و تحقیقات تهران سارا سنجریان sara sanjarian islamic azad university, science & research branchآزاد اسلامی، واحد علوم و تحقیقات تهران الهام خلیلی elham khalili special medical centerمرکز پزشکی خاص امید آریانی omid aryani special medical centerمرکز پزشکی خاص محسن اخوان سپهی mohsen akhavan sepahi qom university of medical sciecnesدانشگاه علوم پزشکی قم مسعود هوشمند

زمینه و هدف: فردریش آتاکسیا یک بیماری آتوزومال مغلوب است که معمولاً با دیس آرتریا، ضعف عضله، اسپاسم در اندام های تحتانی، اسکولیوز، عملکرد بد مثانه، نداشتن رفلکس در اندام های تحتانی و از دست دادن تعادل و لرزش همراه است. تقریباً دوسوم افراد frda (friedreich's ataxia) کاردیومیوپاتی دارند و بیشتر از 30% مبتلا به دیابت شیرین هستند. افراد دارای frda٬ موتاسیون های قابل شناسایی در ژن fxn می باشند. رایج ت...

2015
Sara Anjomani Virmouni Vahid Ezzatizadeh Chiranjeevi Sandi Madhavi Sandi Sahar Al-Mahdawi Yogesh Chutake Mark A. Pook

Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by a GAA repeat expansion mutation within intron 1 of the FXN gene, resulting in reduced levels of frataxin protein. We have previously reported the generation of human FXN yeast artificial chromosome (YAC) transgenic FRDA mouse models containing 90-190 GAA repeats, but the presence of multiple GAA repeats wi...

Journal: :Human molecular genetics 2013
Ping K Chan Raul Torres Cihangir Yandim Pui P Law Sanjay Khadayate Marta Mauri Crina Grosan Nadine Chapman-Rothe Paola Giunti Mark Pook Richard Festenstein

Large intronic expansions of the triplet-repeat sequence (GAA.TTC) cause transcriptional repression of the Frataxin gene (FXN) leading to Friedreich's ataxia (FRDA). We previously found that GAA-triplet expansions stimulate heterochromatinization in vivo in transgenic mice. We report here using chromosome conformation capture (3C) coupled with high-throughput sequencing that the GAA-repeat expa...

Journal: :Clinical chemistry 2013
Devin Oglesbee Charles Kroll Oleksandr Gakh Eric C Deutsch David R Lynch Ralitza Gavrilova Silvia Tortorelli Kimiyo Raymond Dimitar Gavrilov Piero Rinaldo Dietrich Matern Grazia Isaya

BACKGROUND Friedreich ataxia (FRDA) is caused by reduced frataxin (FXN) concentrations. A clinical diagnosis is typically confirmed by DNA-based assays for GAA-repeat expansions or mutations in the FXN (frataxin) gene; however, these assays are not applicable to therapeutic monitoring and population screening. To facilitate the diagnosis and monitoring of FRDA patients, we developed an immunoas...

2012
Timothy E. Richardson Amanda E. Yu Yi Wen Shao-Hua Yang James W. Simpkins

Estrogen and estrogen-related compounds have been shown to have very potent cytoprotective properties in a wide range of disease models, including an in vitro model of Friedreich's ataxia (FRDA). This study describes a potential estrogen receptor (ER)-independent mechanism by which estrogens act to protect human FRDA skin fibroblasts from a BSO-induced oxidative insult resulting from inhibition...

2013
Chiranjeevi Sandi Sahar Al-Mahdawi Mark A. Pook

Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by homozygous expansion of a GAA·TTC trinucleotide repeat within the first intron of the FXN gene, leading to reduced FXN transcription and decreased levels of frataxin protein. Recent advances in FRDA research have revealed the presence of several epigenetic modifications that are either directly or indirect...

Journal: :Genomics 2006
Sahar Al-Mahdawi Ricardo Mouro Pinto Dhaval Varshney Lorraine Lawrence Margaret B Lowrie Sian Hughes Zoe Webster Julian Blake J Mark Cooper Rosalind King Mark A Pook

Friedreich ataxia (FRDA) is a neurodegenerative disorder caused by an unstable GAA repeat expansion mutation within intron 1 of the FXN gene. However, the origins of the GAA repeat expansion, its unstable dynamics within different cells and tissues, and its effects on frataxin expression are not yet completely understood. Therefore, we have chosen to generate representative FRDA mouse models by...

Journal: :Human molecular genetics 2000
P Cavadini C Gellera P I Patel G Isaya

Frataxin is a nuclear-encoded mitochondrial protein widely conserved among eukaryotes. Human frataxin (fxn) is severely reduced in Friedreich ataxia (FRDA), a frequent autosomal recessive neuro- and cardio-degenerative disease. Whereas the function of fxn is unknown, the yeast frataxin homolog (Yfh1p) has been shown to be involved in mitochondrial iron homeostasis and protection from free radic...

2011
Eunah Kim Marek Napierala Sharon Y. R. Dent

Friedreich's ataxia (FRDA) is caused by biallelic expansion of GAA repeats leading to the transcriptional silencing of the frataxin (FXN) gene. The exact molecular mechanism of inhibition of FXN expression is unclear. Herein, we analyze the effects of hyperexpanded GAA repeats on transcription status and chromatin modifications proximal and distal to the GAA repeats. Using chromatin immunopreci...

Journal: :Human molecular genetics 2013
Michele M P Lufino Ana M Silva Andrea H Németh Javier Alegre-Abarrategui Angela J Russell Richard Wade-Martins

Friedreich's ataxia (FRDA) is caused by large GAA expansions in intron 1 of the frataxin gene (FXN), which lead to reduced FXN expression through a mechanism not fully understood. Understanding such mechanism is essential for the identification of novel therapies for FRDA and this can be accelerated by the development of cell models which recapitulate the genomic context of the FXN locus and al...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید